5-Amino-1MQ is a metabolic enhancer peptide. Typical research dosing is daily oral or injection, and the body of supporting research is preclinical / early human.
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme involved in fat cell metabolism. Technically it is not a peptide, but it is sold in the peptide market and used by the same community. By inhibiting NNMT, it may increase NAD+ levels in fat tissue and shift metabolism toward fat burning. Think of it as targeting fat cells at the enzyme level rather than through appetite suppression.
How does NNMT inhibition work? NNMT is overexpressed in obesity and metabolic disease. It consumes SAM (S-adenosylmethionine) and produces 1-methylnicotinamide, depleting methyl donors and slowing metabolism. By blocking NNMT, 5-Amino-1MQ preserves SAM and raises NAD+ levels. Higher NAD+ activates sirtuins which regulate mitochondrial biogenesis and fat oxidation. The result is fat cells that burn more energy and become less efficient at storing fat.
What does the research actually show? Early stage. Promising animal data on fat reduction without calorie restriction. No large human clinical trials yet. In preclinical mouse studies, it prevented obesity even when subjects were fed a high-fat diet. The mechanism is well-understood but the clinical evidence in humans is thin. Position it honestly as an interesting research compound, not a proven weight loss drug.
Unlike GLP-1 peptides that work by suppressing appetite, 5-Amino-1MQ targets metabolism at the cellular level. Semaglutide and tirzepatide make you eat less. 5-Amino-1MQ makes fat cells burn more. Some users stack them. The evidence for stacking is anecdotal, not clinical. If you want to combine approaches, start with one compound first and add the second after a few weeks.
5-Amino-1MQ is available in both oral capsule form and injectable form. Oral capsules are more common because most users who want to inject already have GLP-1s for that purpose. In Philippines, it is available research-grade. Often comes in capsule form rather than injectable, which makes it more accessible for users who do not want to inject. For what to ask a seller, see the supply index. Verify purity via the COA guide. For legal context, see the peptide legality guide.
For enhanced fat loss protocols, 5-Amino-1MQ is often combined with retatrutide or tirzepatide. Users also stack it with AOD-9604 for targeting stubborn fat areas. The combination of appetite suppression (GLP-1) plus cellular fat burning (5-Amino-1MQ) is popular in the biohacking weight loss community.
NNMT Inhibition: NNMT is overexpressed in obesity and metabolic disease. It consumes SAM and produces 1-methylnicotinamide, depleting methyl donors and slowing metabolism. By blocking NNMT, 5-Amino-1MQ preserves SAM and raises NAD+ levels.
NAD+ Elevation: Higher NAD+ activates sirtuins (particularly SIRT1 and SIRT3) which regulate mitochondrial biogenesis, fat oxidation, and energy expenditure. This effectively raises the metabolic rate of fat cells.
Adipocyte Reprogramming: Preclinical data shows 5-Amino-1MQ can cause fat cells to take on characteristics of "beige" fat, a more metabolically active form that burns energy through thermogenesis rather than storing it.
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Starting | 50mg | Once daily | Weeks 1–2 |
| Standard | 100mg | Once daily | Weeks 3–8 |
| Advanced | 100–150mg | Once daily | Ongoing |
Always start at the lowest effective dose and titrate up gradually.
Turning a dose in milligrams into units on a syringe is arithmetic, not judgement. The reconstitution calculator does it for any vial size, and the rest of the calculator set covers cost per milligram and route comparison.
Vials at Primara Labs, our partner and supplier, ship from stock already inside the Philippines, so an order has no customs leg. Their catalogue is the shortest route to what is listed locally and at what price, and anything outside it goes through the same WhatsApp thread. View the Primara Labs catalogue
Adjustment phase. Some users report mild fatigue as cellular metabolism shifts. No dramatic changes visible yet.
Increased energy levels reported by most users. Subtle improvements in body composition may begin, especially when combined with exercise.
More noticeable changes in body composition, particularly visceral fat. Best results seen when stacked with dietary modifications or GLP-1 peptides.
Everything above is research framing. If you have got as far as wanting a vial, the catalogue at Primara Labs, our partner and supplier, is the shortest way to see what is held inside the Philippines and at what price. View the Primara Labs catalogue
Our partner and supplier
Primara Labs, our partner and supplier, ships from inventory already inside the Philippines, so there is no customs leg: vials are batch-numbered, Metro Manila orders dispatch same day, the rest of the country lands in one to three business days, and every order gets 10% off. The current list sits on one page, and anything you cannot see on it goes through the same WhatsApp thread.
View the Primara Labs catalogueThe supply index covers what to ask a seller before paying, and why quoted prices vary so widely.
Risk · Disclosure · Editorial Status
This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician (ideally one with peptide-specific clinical experience) before starting any compound, adjusting a dose, or discontinuing therapy.
In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.
Editorial Status
Independent · Non-clinical
Affiliation
Not a clinic · Not a pharmacy
Last Updated
August 27, 2026
